glp 1 new drug Eli Lilly to seek approval of GLP-1 weight-loss this year How GLP-1 medications are transforming

2013;166(240249):e241

(Yes, liraglutide is also known as Victoza, but thats the formulation approved for diabetes management rather than weight loss Very much like the Ozempic and Wegovy story.) Saxenda, like a successful spin-off of a popular TV series, has been making waves since its FDA approval in 2014 for chronic weight management in adults with obesity or overweight and at least one weight-related comorbidity

Both medications achieve outcomes that approach bariatric surgery results without requiring invasive procedures

Appetite regulation GLP-1 is involved in the regulation of appetite and satiety

The oral drug also had a safety profile consistent with its injectable formulation

The primary objective of the study was to evaluate the safety and tolerability of VK2735 administered as an oral tablet once daily for 28 days